1

The Brave New World of Early Treatment of Multiple Sclerosis: Using the Molecular Biomarkers CXCL13 and Neurofilament Light to Optimize Immunotherapy

ndiviukmjtplil
Multiple sclerosis (MS) is a highly heterogeneous disease involving a combination of inflammation. demyelination. and CNS injury. It is the leading cause of non-traumatic neurological disability in younger people. https://www.animationbengal.com/?w=deal-time-the-best-of-shirley-temple-vol-ii-online-now-super-choice
Report this page

Comments

    HTML is allowed

Who Upvoted this Story